Search clinical trials for: High-Dose Carfilzomib
Total 416 results
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
M.D. Anderson Cancer CenterAmgenCompleted
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
AmgenCompletedMultiple MyelomaUnited States, Canada
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
AmgenCompletedLymphoma | Small Cell Lung Cancer | Multiple Myeloma | Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumors | Renal CancerUnited States
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Emory UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Donald C. Goff, MDPfizerCompletedSchizophreniaUnited States
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
AmgenCompleted
-
Oslo University HospitalUniversity of OsloCompleted
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Anhui Medical UniversityUnknownSelf Efficacy | Drug ToxicityChina
-
AmgenMultiple Myeloma Research FoundationApproved for marketing
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
AmgenCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Hodgkin's DiseaseUnited States
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
AmgenCompleted
-
AmgenCompletedRenal Insufficiency | Multiple MyelomaUnited States
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple MyelomaUnited States
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Massachusetts General HospitalCompletedMesenchymal TumorUnited States
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsWithdrawn
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Vanderbilt UniversityUniversity of Pittsburgh; MCM Vaccines B.V.CompletedPediatric Solid Organ Transplant PatientsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Saad Jamshed MDSanofiCompletedCancer | Influenza Viral InfectionsUnited States
-
Washington University School of MedicineCompleted
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Leukemia, Plasma CellUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia, Myeloid, ChronicUnited States
-
Ohio State University Comprehensive Cancer CenterAmgenCompletedHematopoietic/Lymphoid Cancer | Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Tragara Pharmaceuticals, Inc.CompletedMultiple Myeloma | AML | Blast Crisis | MDS | ALLUnited States
-
NovartisAmgenTerminated
-
The University of Texas Health Science Center at...Withdrawn
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Orthomyxoviridae Infection | Myxovirus InfectionUnited States
-
Nantes University HospitalCompleted
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
University of RochesterMassey Cancer CenterCompleted
-
Sheba Medical CenterUnknown